BioDiscovery is proud to participate in the upcoming Cancer Genomics Consortium (CGC) 12th Annual Meeting on August 1-4th, 2021.
The 12th Annual Cancer Genomics Consortium (CGC) Meeting has gone virtual and BioDiscovery is excited, once again, to provide industry support to this great organization with amazing and dedicated members.
View the CGC 2021 program to learn if this is the right meeting for you!
When you're ready, register for the meeting here.
Don't forget to bookmark this scientific talk on machine learning methods to sub-classify Renal Cell Carcinoma tumors presented by our Founder, Dr. Soheil Shams, in collaboration with researchers at the University of Washington. ⬇️
Wednesday, August 4th, 2021, 3:55 – 4:25 PM EDT
CGC Session 10: Bioinformatics: Applications and Development
Computer-aided cytogenomic classification of renal cell carcinoma
Soheil Shams, BioDiscovery, Inc.
BioDiscovery customer presentations:
Sunday, August 1st, 2021, 1:25 – 2:25 PM EDT
CGC Session 1: Brain Tumors - Molecular Landscape and Emerging Targets
Glioblastomas with MAPK pathway alterations show low grade histologic features and present novel therapeutic targets
David Meredith, Brigham and Women’s Hospital
Visit BioDiscovery’s virtual exhibit hall booth, which will be staffed by real people, so you can live chat or video call us via Zoom.
Monday, August 2nd
1:20 - 2:35 PM
4:35 – 5:40 PM
Tuesday, August 3rd
1:40 – 2:15 PM
4:30 – 5:30 PM
Wednesday, August 4th
1:20 – 2:35 PM
2:35 PM Vendor Showcase: BioDiscovery (3 mins)
4:30 – 5:30 PM